Literature DB >> 25231106

Sphingosine kinase 1 (Sphk1) negatively regulates platelet activation and thrombus formation.

Patrick Münzer1, Evi Schmid1, Britta Walker1, Anna Fotinos2, Madhumita Chatterjee2, Dominik Rath2, Sebastian Vogel2, Sascha M Hoffmann3, Katja Metzger2, Peter Seizer2, Tobias Geisler2, Meinrad Gawaz2, Oliver Borst4, Florian Lang5.   

Abstract

Sphingosine 1-phosphate (S1P) is a powerful regulator of platelet formation. Enzymes generating S1P include sphingosine kinase 1. The present study thus explored the role of sphingosine kinase 1 in platelet formation and function. Activation-dependent platelet integrin αIIbβ3 activation and secretion of platelets lacking functional sphingosine kinase 1 (sphk1(-/-)) and of wild-type platelets (sphk1(+/+)) were determined utilizing flow cytometry and chronolume luciferin assay. Cytosolic Ca(2+) activity ([Ca(2+)]i) and aggregation were measured using fura-2 fluorescence and aggregometry, respectively. In vitro platelet adhesion and thrombus formation were evaluated using a flow chamber with shear rates of 1,700 s(-1). Activation-dependent increase of [Ca(2+)]i, degranulation (release of alpha and dense granules), integrin αIIbβ3 activation, and aggregation were all significantly increased in sphk1(-/-) platelets compared with sphk1(+/+) platelets. Moreover, while platelet adhesion and thrombus formation under arterial shear rates were significantly augmented in Sphk1-deficient platelets, bleeding time and blood count were unaffected in sphk1(-/-) mice. In conclusion, sphingosine kinase 1 is a powerful negative regulator of platelet function counteracting degranulation, aggregation, and thrombus formation.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  [Ca2+]i; platelet activation; sphingosine kinase 1; thrombus formation

Mesh:

Substances:

Year:  2014        PMID: 25231106      PMCID: PMC4233262          DOI: 10.1152/ajpcell.00029.2014

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  55 in total

Review 1.  Platelet activation and blood coagulation.

Authors:  Johan W M Heemskerk; Edouard M Bevers; Theo Lindhout
Journal:  Thromb Haemost       Date:  2002-08       Impact factor: 5.249

2.  Evidence for the presence of multiple forms of Sph kinase in human platelets.

Authors:  Y Banno; M Kato; A Hara; Y Nozawa
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

3.  Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum.

Authors:  Y Yatomi; Y Igarashi; L Yang; N Hisano; R Qi; N Asazuma; K Satoh; Y Ozaki; S Kume
Journal:  J Biochem       Date:  1997-05       Impact factor: 3.387

4.  Integrin alpha(IIb)beta3 signals lead cofilin to accelerate platelet actin dynamics.

Authors:  Hervé Falet; Gregory Chang; Brigitte Brohard-Bohn; Francine Rendu; John H Hartwig
Journal:  Am J Physiol Cell Physiol       Date:  2005-05-18       Impact factor: 4.249

5.  Functional phenotype of phosphoinositide 3-kinase p85alpha-null platelets characterized by an impaired response to GP VI stimulation.

Authors:  Naohide Watanabe; Hideaki Nakajima; Hidenori Suzuki; Atsushi Oda; Yumiko Matsubara; Masaaki Moroi; Yasuo Terauchi; Takashi Kadowaki; Harumi Suzuki; Shigeo Koyasu; Yasuo Ikeda; Makoto Handa
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

6.  Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720.

Authors:  Maria L Allende; Teiji Sasaki; Hiromichi Kawai; Ana Olivera; Yide Mi; Gerhild van Echten-Deckert; Richard Hajdu; Mark Rosenbach; Carol Ann Keohane; Suzanne Mandala; Sarah Spiegel; Richard L Proia
Journal:  J Biol Chem       Date:  2004-09-30       Impact factor: 5.157

7.  Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2.

Authors:  Donna Woulfe; Hong Jiang; Alicia Morgans; Robert Monks; Morris Birnbaum; Lawrence F Brass
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

8.  Sphingosylphosphorylcholine, a naturally occurring lipid mediator, inhibits human platelet function.

Authors:  Christoph Altmann; Dagmar Meyer Zu Heringdorf; Dilek Böyükbas; Michael Haude; Karl H Jakobs; Martin C Michel
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

9.  Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases.

Authors:  Xiaodong Shu; Weicheng Wu; Raymond D Mosteller; Daniel Broek
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

10.  Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets.

Authors:  Y Yatomi; F Ruan; S Hakomori; Y Igarashi
Journal:  Blood       Date:  1995-07-01       Impact factor: 22.113

View more
  4 in total

1.  The Role of Chemoprophylactic Agents in Modulating Platelet Aggregability After Traumatic Brain Injury.

Authors:  Mackenzie C Morris; Farzaan Kassam; Aron Bercz; Nadine Beckmann; Fabian Schumacher; Erich Gulbins; Amy T Makley; Michael D Goodman
Journal:  J Surg Res       Date:  2019-07-03       Impact factor: 2.192

2.  Exploration of the Sphingolipid Metabolite, Sphingosine-1-phosphate and Sphingosine, as Novel Biomarkers for Aspirin-exacerbated Respiratory Disease.

Authors:  Hoang Kim Tu Trinh; Su-Chin Kim; Kumsun Cho; Su-Jung Kim; Ga-Young Ban; Hyun-Ju Yoo; Joo-Youn Cho; Hae-Sim Park; Seung-Hyun Kim
Journal:  Sci Rep       Date:  2016-11-10       Impact factor: 4.379

3.  Sphingolipid dysregulation due to lack of functional KDSR impairs proplatelet formation causing thrombocytopenia.

Authors:  Tadbir K Bariana; Veerle Labarque; Jessica Heremans; Chantal Thys; Mara De Reys; Daniel Greene; Benjamin Jenkins; Luigi Grassi; Denis Seyres; Frances Burden; Deborah Whitehorn; Olga Shamardina; Sofia Papadia; Keith Gomez; Nihr BioResource; Chris Van Geet; Albert Koulman; Willem H Ouwehand; Cedric Ghevaert; Mattia Frontini; Ernest Turro; Kathleen Freson
Journal:  Haematologica       Date:  2018-11-22       Impact factor: 9.941

4.  Sphingosine-1-phosphate modulates PAR1-mediated human platelet activation in a concentration-dependent biphasic manner.

Authors:  Haonan Liu; Molly L Jackson; Lucy J Goudswaard; Samantha F Moore; James L Hutchinson; Ingeborg Hers
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.